|
|
||||||||

*
Department of Microbiology and Immunology, Kimmel Cancer Center, and
Department of Pathology and Cell Biology, Jefferson Medical College, Philadelphia, PA 19107
The human B-myb gene encodes a
transcriptional regulator that plays an important role in cell cycle
progression, differentiation, and survival. To assess the in vivo role
of B-myb, we investigated the phenotype of mouse
transgenic lines in which B-Myb expression in lymphoid tissues was
driven by the LCK proximal promoter. Overexpression of B-Myb had no
measurable effect on the subsets of splenic and thymic lymphocytes, but
was associated with increased expression of Fas ligand in NK and T
cells. B-Myb-overexpressing splenocytes expressed higher IFN-
levels
and contained higher percentages of cytokine-producing cells than
wild-type (wt) splenocytes, as detected by Western blot analysis and
ELISPOT assays, respectively. Ex vivo-cultured transgenic thymocytes
and splenocytes had decreased survival compared with the corresponding
cells from wt mice, possibly dependent on increased expression of Fas
ligand. In addition, Fas ligand-dependent cytotoxicity of transgenic T
and NK cells was significantly higher than that mediated by their wt
counterparts. Together, these results indicate that B-Myb
overexpression results in T and NK cell activation and increased
cytotoxicity. Therefore, in addition to its well-established role in
proliferation and differentiation, B-myb also appears to be involved in
activation of NK and T cells and in their regulation of Fas/Fas
ligand-mediated cytotoxicity
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |